Stock ACHL ACHILLES THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Achilles Therapeutics plc

Equities

ACHL

US00449L1026

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
0.76 USD -1.86% Intraday chart for Achilles Therapeutics plc -2.93% -14.51%
05/04 Piper Sandler Downgrades Achilles Therapeutics to Neutral From Overweight, Cuts Price Target to $2 From $8 MT
05/04 Chardan Capital Adjusts Achilles Therapeutics Price Target to $6 From $11, Maintains Buy Rating MT

Chart calendar Achilles Therapeutics plc

7fb83109b48b6fda11b076736a731e24.355pzhXFo-aMbw9uBord5XHyiYCuQbASazNyFulgGwU.uLMLvifx2qXcX1cJN-e-limT09nAEsNaKnQYY5kqVD2M3w2MW5rCgd4EPw~c2d79d054a7e2efefe5a2b503dc0ffe7

Upcoming events on Achilles Therapeutics plc

07/05/2024 Q1 2024 Earnings Release (Projected)
06/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
04/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Achilles Therapeutics plc

Today Chardan Cell Therapy Manufacturing Summit
Today LSX World Congress
23/04/2024 Europe ImmunoOncology Summit
04/04/2024 04:15 pm Q4 2023 Earnings Release
29/02/2024 09:00 pm Immuno Oncology 360 Conference
14/11/2023 03:00 am Q3 2023 Earnings Release
02/10/2023 TIL Therapies Summit
06/09/2023 Advanced Therapies Europe Conference
08/08/2023 01:45 am Immuno-Oncology Summit
04/08/2023 04:30 pm Q2 2023 Earnings Release
28/06/2023 09:30 pm Annual General Meeting
21/06/2023 08:40 pm Immuno-Oncology Europe Summit
20/06/2023 03:30 pm SAE Cell and Gene Therapy Conference
10/05/2023 04:45 pm Q1 2023 Earnings Release
03/05/2023 LSX World Congress
24/04/2023 09:00 pm Chardan Genetic Medicines and Cell Therapy Manufacturing Summit
29/03/2023 European Lung Cancer Congress
20/03/2023 BIO Europe Spring
14/03/2023 05:30 pm Oppenheimer Healthcare Conference
09/03/2023 07:10 pm EQT Life Sciences Bio Capital Europe Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00


-60,9
-62,2
2%		-74,7
-72,5
-3.02%		-70,5
-71,7
1.55%
-86,7

EBIT
Million USD		Released
Forecast
Spread 		-33,7


-64,2
-64,4
0.27%		-78,4
-74,8
-4.79%		-75,3
-76,2
1.22%
-85,9

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-61,1
-61,0
-0.02%		-71,1
-64,1
-10.78%		-69,2
-72,0
3.99%
-80,0

Net income
Million USD		Released
Forecast
Spread 		-33,2


-61,1
-61,5
0.6%		-71,2
-64,2
-10.84%		-69,7
-72,0
3.29%
-80,0

EPS
USD		Released
Forecast
Spread 		0,00


-2,13
-4,30
50.43%		-1,82
-1,67
-8.82%		-1,74
-1,38
-26.55%
-1,06

Announcement Date25/03/2101/03/2207/03/2304/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-18,5
-18,7
1.23%		-19,0
-20,6
7.82%		-20,5
-21,1
2.62%		-16,0
-22,7
29.25%		-22,8
-19,3
-18.59%		-18,6
-20,4
9.11%		-18,1
-20,7
12.53%		-19,1
-19,9
4.16%		-19,5
-20,4
4.55%
-20,5


-21,1


-21,8


-22,6


-22,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,2
-18,2
-0.39%		-17,3
-21,1
17.86%		-17,3
-21,1
18.19%		-12,4
-22,5
44.84%		-24,0
-17,1
-40.46%		-17,5
-19,8
11.77%		-16,9
-21,0
19.62%		-16,7
-20,5
18.5%		-18,1
-21,0
13.69%
-20,0


-20,0


-20,0


-20,0


-22,0

Net income
Million USD		Released
Forecast
Spread 		-18,2
-18,6
2.12%		-17,4
-20,4
14.84%		-17,3
-20,9
17.27%		-12,5
-22,5
44.66%		-24,1
-17,1
-40.7%		-17,5
-19,8
11.55%		-16,8
-21,0
19.78%		-16,7
-20,5
18.62%		-18,6
-21,0
11.29%
-20,0


-20,0


-20,0


-20,0


-22,0

EPS
USD		Released
Forecast
Spread 		-0,45
-0,76
40.79%		-0,45
-0,51
12.5%		-0,44
-0,57
22.95%		-0,32
-0,65
50.54%		-0,61
-0,22
-174.16%		-0,44
-0,49
9.28%		-0,42
-0,40
-5%		-0,42
-0,40
-5%		-0,46
-0,15
-217.24%
-0,48


-0,49


-0,49


-0,36


-0,52

Announcement Date01/03/2210/05/2209/08/2208/11/2207/03/2310/05/2304/08/2313/11/2304/04/24-----

Upcoming sector events for Achilles Therapeutics plc

Today 01:35 am QIAGEN N.V.: Q1 2024 Earnings Release
30/04/2024 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
01/05/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
01/05/2024 04:00 pm UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release
01/05/2024 04:00 pm BIO-TECHNE CORPORATION: Q3 2024 Earnings Release
01/05/2024 04:30 pm ALKERMES PLC: Q1 2024 Earnings Release
02/05/2024 VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release
More events

Past sector events for Achilles Therapeutics plc

Today BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
Today SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
Today JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
Today MORPHOSYS AG: Q1 2024 Earnings Release
27/04/2024 GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
27/04/2024 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 10:30 am BB BIOTECH AG: Q1 2024 Earnings Release
26/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
26/04/2024 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ACHL Stock
  4. Calendar Achilles Therapeutics plc